Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Endovascular is a U.S. vascular care organization focused on outpatient, minimally invasive endovascular treatment for peripheral artery disease and limb salvage. The company provides administrative and business support services to affiliated interventional radiologists and vascular specialists and operates or supports Joint Commission-accredited vascular centers. Its core commercial focus is amputation prevention, especially for patients with advanced peripheral artery disease and critical limb ischemia, using image-guided procedures such as angioplasty, atherectomy, and stent placement. The organization also highlights services in dialysis access management and selected embolization and venous procedures. Overall, it is a healthcare delivery and practice-management business rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Endovascular.